Literature DB >> 7632822

Expression pattern of matrix metalloproteinases in human liver.

R Lichtinghagen1, T Helmbrecht, B Arndt, K H Böker.   

Abstract

Antibodies were raised against seven major matrix metalloproteinases: stromelysin-1 (MMP-3), stromelysin-2 (MMP-10), stromelysin-3 (MMP-11), interstitial collagenase (MMP-1), M(r) 72,000 type IV collagenase (72 kDa type IV collagenase, MMP-2), M(r) 92,000 type IV collagenase (92 kDa type IV collagenase, MMP-9) and matrilysin (PUMP, MMP-7) as well as against prolyl 4-hydroxylase, to study the expression of these collagenolytic enzymes in normal liver in relation to the activity of collagen synthesis. Tissue samples of four normal human livers, three hepatocellular carcinomas and one cholangiocellular carcinoma were analysed. In normal liver we found expression of stromelysin-1, stromelysin-3, interstitial collagenase, M(r) 72,000 and M(r) 92,000 type IV collagenases and varying expression of prolyl 4-hydroxylase. Stromelysin-2 was inconsistently detectable; matrilysin was not found. In hepatocellular carcinoma the expression pattern of matrix metalloproteinases showed only minor changes compared with the normal tissue; stronger signals than in normal tissue were seen for stromelysin-1, and stromelysin-2 was also strongly positive. M(r) 72,000 and M(r) 92,000 type IV collagenases and interstitial collagenase were less strongly expressed; stromelysin-3 was unchanged. Expression of prolyl 4-hydroxylase was also increased compared with normal liver. Matrilysin was only seen in cholangiocellular carcinoma, which showed a completely different pattern of matrix metalloproteinase expression. Our results show that metalloproteinases are expressed in human liver with much greater abundance than previously described. Their expression pattern is not changed fundamentally in hepatocellular carcinoma but is completely different from that of other tumour tissues such as cholangiocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632822     DOI: 10.1515/cclm.1995.33.2.65

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  9 in total

1.  Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes.

Authors:  A J Demetris; E C Seaberg; A Wennerberg; J Ionellie; G Michalopoulos
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

2.  Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth.

Authors:  Annette Lebeau; Claudia Müller-Aufdemkamp; Clarissa Allmacher; Ulrich Sauer; Andreas Nerlich; Ralf Lichtinghagen; Udo Löhrs
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

3.  Expression of CD147, PCNA, VEGF, MMPs and their clinical significance in the giant cell tumor of bones.

Authors:  Yue-Hu Han; Bo Gao; Jing-Hui Huang; Zhen Wang; Zheng Guo; Qiang Jie; Liu Yang; Zhuo-Jing Luo
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

4.  Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.

Authors:  E Kerkelä; R Ala-aho; J Lohi; R Grénman; V M-Kähäri; U Saarialho-Kere
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

5.  Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.

Authors:  E Hesse; P B Musholt; E Potter; T Petrich; M Wehmeier; R von Wasielewski; R Lichtinghagen; T J Musholt
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640

Review 6.  Matrix metalloproteinases in liver injury, repair and fibrosis.

Authors:  Sergio Duarte; John Baber; Takehiro Fujii; Ana J Coito
Journal:  Matrix Biol       Date:  2015-01-16       Impact factor: 11.583

7.  Induction of synthesis of matrix metalloproteinases by interleukin-6; evidence for hepatic regeneration following hemi-hepatectomy.

Authors:  Thamer Alghamdi; Ihab Shafek Atta; Mohamed El-Refaei
Journal:  Clin Exp Hepatol       Date:  2020-05-27

8.  Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury.

Authors:  Andrea Villar-Lorenzo; Patricia Rada; Esther Rey; Patricia Marañón; Ana I Arroba; Beatriz Santamaría; Jorge Sáiz; Francisco J Rupérez; Coral Barbas; Carmelo García-Monzón; Ángela M Valverde; Águeda González-Rodríguez
Journal:  Dis Model Mech       Date:  2019-07-16       Impact factor: 5.758

Review 9.  Molecular Advances in MAFLD-A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis.

Authors:  Adrian Kołakowski; Sylwia Dziemitko; Aleksandra Chmielecka; Hubert Żywno; Wiktor Bzdęga; Tomasz Charytoniuk; Adrian Chabowski; Karolina Konstantynowicz-Nowicka
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.